SCHEMBL8599488

SCHEMBL8599488

O=S(=O)(O)c1cc(S(=O)(=O)O)c2ccccc2c1.[Na].[Na].[Na].[Na]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
CYP2C9 P11712 4/20 0.50
CYP1A2 P05177 4/20 0.50
CYP2C19 P33261 3/20 0.50
HSD17B10 Q99714 3/20 0.50
HIF1A Q16665 3/20 0.50
MAPK1 P28482 2/20 0.50
ALOX15 P16050 1/20 0.50
ATIC P31939 1/20 0.50
CASP6 P55212 4/20 0.49
TSHR P16473 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MPL P40238 4/20 0.46
NSD2 O96028 3/20 0.46
CTRC Q99895 2/20 0.46
DUSP3 P51452 2/20 0.46
PTPN5 P54829 2/20 0.46
PTPN11 Q06124 2/20 0.46
CASP7 P55210 1/20 0.46
NT5E P21589 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1145407 1.00 ALDH1A1 (0.50) ALDH1A1CYP2C9CYP1A2CYP2C19HSD17B10
SCHEMBL29421128 1.00 ALDH1A1 (0.50) ALDH1A1CYP2C9CYP1A2CYP2C19HSD17B10
SCHEMBL28030504 0.98 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2CYP2C19HSD17B10
SCHEMBL27609745 0.98 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2CYP2C19HSD17B10
Ammonia Solution, Strong SCHEMBL27845809 0.98 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2CYP2C19HSD17B10
SCHEMBL27788769 0.98 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2CYP2C19HSD17B10
Potassium SCHEMBL9556360 0.98 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2CYP2C19HSD17B10
SCHEMBL27625969 0.98 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2CYP2C19HSD17B10
SCHEMBL27085691 0.98 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2CYP2C19HSD17B10
SCHEMBL25940533 0.87 ALDH1A1 (0.45) ALDH1A1CYP2C9CYP1A2CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820284-A1 BIOLOGICALLY ACTIVE UREIDO DERIVATIVES USEFUL IN THE TREATMENT OF MULTIPLE SCLEROSIS PHARMACIA & UPJOHN S.p.A. (IT) 1998-01-28 EP disclosed
WO-1997028796-A1 BIOLOGICALLY ACTIVE UREIDO DERIVATIVES USEFUL IN THE TREATMENT OF MULTIPLE SCLEROSIS PHARMACIA & UPJOHN S.P.A. (IT) 1997-08-14 WO disclosed